Multiple Manufacturers



Multiple Manufacturers

Brovana HCPCS:


HCPCS Code Descriptor:

Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms


J Code

Brovana NDCs:

63402-0911-64, 70436-0151-58, 63402-0911-30, 70436-0151-57, 69097-0168-53, 69097-0168-64, 70756-0612-60, 69097-0168-87, 70756-0612-70

Primary Type:


Generic/Specialty Status:


Route of Administration:


Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

70756-0612-60, 70756-0612-70

About Brovana:

BROVANA is a Respiratory drug manufactured by Sunovion Pharma and administered via the Inhalation route of administration. The J Code: J7605 is aligned to the drug BROVANA.

Brovana is a drug used to treat breathing problems caused by a variety of illnesses, such as COPD, chronic bronchitis and emphysema. Brovana is a long-term maintenance treatment that aims to prevent and decrease wheezing and shortness of breath in patients who struggle with chronic breathing issues. Brovana is what is known as a bronchodilator. It works by relaxing your airway's surrounding muscles so they open up, allowing patients to breathe more easily. Brovana is typically administered by nebulizer or inhalation.


J7605 Added Date:

January 1, 2008

J7605 Effective Date:

January 1, 2008

J7605 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Brovana billing and coding information.
Our team did not identify a source for Brovana patient assistance information. Please reach out to our team if you feel that this is a mistake.
BROVANA prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for BROVANA. Please check back in a few weeks.